Korean J Fam Med.  2009 Mar;30(3):197-201. 10.4082/kjfm.2009.30.3.197.

Change of Selection to Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang . Gyeongju Primary Care Research Network

• Yun ZY
• Lee DW
• Jung HS
• Park KH
• Lee SH
• Park JJ
• Kim DI
• Ki JM
• Cho KR
• Song JS
• Choi S
• U CH
• Jung TH
• Jung SH
• Kim SW
• Kim I

• KMID: 2235628
• DOI: http://doi.org/10.4082/kjfm.2009.30.3.197

Abstract

BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) or Angiotensin II type 1 receptor blockers (ARBs) are compelling indication drugs for hypertensive patients with diabetes mellitus. But prescription rate in 2005 year study of Pohang . Gyeongju area was only 30.8%. Therefore, a study on the change of prescription rate in the same area after 3 years was done.
METHODS
During three months from January 2008, 152 hypertensive patients with diabetes mellitus on their prescribed antihypertensive medications by 9 family physicians in visiting order were analyzed. After the analysis, the infl uencing factors for such prescriptions were ascertained by directly visiting each physicians who prescribed them.
RESULTS
A regimen of 16 antihypertensive agents were prescribed by these family physicians. Prescription count of ACEIs or ARBs was 101 cases (66.4%). ACEIs single therapy was 19 cases (12.5%), ACEIs combination therapy was 7 cases (4.6%), ARBs single therapy was 31 cases (20.4%) and ARBs combination therapy was 44 cases (28.9%). The ACEIs or ARBs which were selected by physicians that followed "compelling indication" was 5 (55.6%), "excellent reduce pressure effect" was 3 (33.3%) and "public relations of new medicine" was 1 (11.1%).
CONCLUSION
In prescribing antihypertensive agents for patients with diabetes mellitus, selection of ACEIs or ARBs was increased from 30.8% to 66.4%. Education of recommended standard by participating in such study and developing of excellent new medicines may increase such change.

Keyword

Diabetes Mellitus; Hypertension; Angiotensin Converting Enzyme Inhibitors; Angiotensin II Type 1 Receptor Blockers

MeSH Terms

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Diabetes Mellitus
Humans
Hypertension
Physicians, Family
Prescriptions
Primary Health Care
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents